BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26775133)

  • 1. Renin-angiotensin-aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels.
    Mikolasevic I; Zaputovic L; Zibar L; Begic I; Zutelija M; Klanac A; Majurec I; Simundic T; Minazek M; Orlic L
    Eur J Intern Med; 2016 Apr; 29():98-103. PubMed ID: 26775133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.
    Orlić L; Mikolasević I; Sladoje-Martinović B; Bubić I; Pavletić-Persić M; Racki S
    Coll Antropol; 2013 Sep; 37(3):809-14. PubMed ID: 24308221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients - a cross-sectional prospective observational clinical study.
    Heleniak Z; Illersperger S; Brakemeier S; Bach P; Dębska-Ślizień A; Budde K; Halleck F
    Acta Biochim Pol; 2020 Dec; 67(4):613-622. PubMed ID: 33332078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.
    Morales E; Gutiérrez E; Caro J; Sevillano A; Rojas-Rivera J; Praga M
    Nefrologia; 2015; 35(6):554-61. PubMed ID: 26519114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL; Taber DJ
    Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
    Zakrzewska A; Tylicki L; Debska-Slizien A
    Transplant Proc; 2018; 50(6):1838-1841. PubMed ID: 30056911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE; Cohen J; Vivera M; Zaltzman JS
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
    Wu PC; Wu CJ; Lin CJ; Pan CF; Chen CY; Huang TM; Wu CH; Lin SL; Chen YM; Chen L; Wu VC; ;
    Clin Pharmacol Ther; 2015 Oct; 98(4):442-9. PubMed ID: 26082272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
    Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
    Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.
    Zakrzewska A; Tylicki L; Debska-Slizien A
    Transplant Proc; 2018; 50(6):1834-1837. PubMed ID: 30056910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation.
    Stevens KK; Patel RK; Clancy M; Jardine AG
    Transplantation; 2010 Mar; 89(6):707-9. PubMed ID: 20010330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
    Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
    Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
    Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.